Finance

Beta
Lists
3ZO0:FRA
Acurx Pharmaceuticals Inc
-100.00%
(-5.09) 1D
Jun 5, 10:56:49 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3ZO0...
Mkt. cap
7.22M
Volume
0.00
52-wk high
€244.00
52-wk low
€101.80
No. of employees
4
Mkt. cap
7.22M
Volume
0.00
52-wk high
€244.00
52-wk low
€101.80
No. of employees
4
News stories
From sources across the web
About Acurx Pharmaceuticals Inc
CEODavid P Luci
Employees4
Founded2017
Headquarters-
SectorBiotechnology
Websiteacurxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
524.21K
429.69K
281.81K
341.47K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
1.60M
1.34M
1.37M
Operating expense
2.27M
2.03M
1.62M
1.72M
Total operating expenses
2.27M
2.03M
1.62M
1.72M
Operating income
-2.27M
-2.03M
-1.62M
-1.72M
Other non operating income
-
-
-
-
EBT including unusual items
-2.25M
-1.99M
-1.58M
-1.68M
EBT excluding unusual items
-2.25M
-1.99M
-1.58M
-1.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.25M
-1.99M
-1.58M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-1.89
-1.23
-0.31
-0.62
Interest and investment income
23.40K
35.91K
38.84K
35.01K
Interest expense
-
-
-
-
Net interest expenses
23.40K
35.91K
38.84K
35.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer